340B PATIENTS Act of 2025
Sponsored By: Representative Matsui, Doris O. [D-CA-7]
Introduced
Summary
Protect 340B discounts regardless of where drugs are dispensed. This bill would clarify that manufacturers must offer discounted outpatient drug pricing to 340B covered entities no matter how or where drugs are dispensed, and would bar conditions that limit access or change purchasing practices.
Show full summary
- Hospitals, health centers, and clinics would keep access to 340B prices when they use in-house or contract pharmacies because the bill would explicitly apply the program rules to drugs dispensed through contracted pharmacies.
- Patients in served communities would be more likely to get discounted outpatient drugs at local or contracted pharmacies since manufacturers could not impose extra rules that block those dispensing channels.
- Drug manufacturers would face stronger enforcement. The bill would add civil monetary penalties for intentional violations, up to $2 million per day, and would require the Secretary to issue regulations and a claims process within 180 days.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Big fines for 340B violations
The bill would let the Secretary set civil fines for intentional 340B rule violations. The fines could be up to $2,000,000 per day, and would run until the violation ends. The Secretary would have 180 days after enactment to issue the rules and standards. Covered entities would be able to bring claims through an administrative process. The bill also clarifies that certain penalties apply when a manufacturer overcharges a covered entity.
Drug discounts honored at contract pharmacies
This bill would require drug makers to honor 340B discounts no matter where a drug is dispensed. The same rules would apply when a hospital or clinic uses contract pharmacies. Manufacturers would be barred from adding special conditions, like delivery limits or extra data demands, unless the Secretary approves them in advance. It would apply when the covered entity buys the drug at or below the 340B ceiling price. If enacted, this could help low-income and uninsured patients keep access to lower-priced outpatient drugs.
Sponsors & CoSponsors
Sponsor
Matsui, Doris O. [D-CA-7]
CA • D
Cosponsors
Trahan
MA • D
Sponsored 7/22/2025
Rep. Tonko, Paul [D-NY-20]
NY • D
Sponsored 7/22/2025
Rep. Davids, Sharice [D-KS-3]
KS • D
Sponsored 7/22/2025
McCollum
MN • D
Sponsored 7/22/2025
Rep. Thanedar, Shri [D-MI-13]
MI • D
Sponsored 7/22/2025
Rep. Tlaib, Rashida [D-MI-12]
MI • D
Sponsored 7/22/2025
Rep. Frost, Maxwell [D-FL-10]
FL • D
Sponsored 7/22/2025
Rep. Castor, Kathy [D-FL-14]
FL • D
Sponsored 7/22/2025
Escobar
TX • D
Sponsored 7/29/2025
McGovern
MA • D
Sponsored 7/29/2025
Rep. Krishnamoorthi, Raja [D-IL-8]
IL • D
Sponsored 8/15/2025
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 9/16/2025
Rep. Jayapal, Pramila [D-WA-7]
WA • D
Sponsored 9/23/2025
Rep. Tokuda, Jill N. [D-HI-2]
HI • D
Sponsored 11/7/2025
Rep. Lynch, Stephen F. [D-MA-8]
MA • D
Sponsored 11/7/2025
Rep. Cleaver, Emanuel [D-MO-5]
MO • D
Sponsored 12/2/2025
Rep. Moore, Gwen [D-WI-4]
WI • D
Sponsored 2/12/2026
Rep. Torres, Ritchie [D-NY-15]
NY • D
Sponsored 4/9/2026
Rep. Vindman, Eugene Simon [D-VA-7]
VA • D
Sponsored 4/22/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov